SECsense Logo

PMGC Holdings Inc. 8-K Report: Key Insights & Developments as of Dec 23, 2024

$ELAB
Form 8-K
Filed on: 2025-01-07
Source
PMGC Holdings Inc. 8-K Report: Key Insights & Developments as of Dec 23, 2024

Based on the provided XML section of a financial report, here are the key insights and information extracted:

  1. Entity Information:
  • Name: PMGC Holdings Inc. (likely associated with Elevai Labs Inc.)
  • CIK: 0001840563
  • SEC Filing Type: 8-K (a report of unscheduled material events or corporate changes)
  • Filing Date: December 23, 2024
  • Location: 120 Newport Center Drive, Ste. 250, Newport Beach, CA 92660
  • Contact Number: 866-794-4940
  1. Stock Information:
  • Common Stock: The company has common stock with a par value of $0.0001.
  • Ticker Symbol: ELAB (listed on NASDAQ)
  1. Financial Period:
  • Reporting Period: The report is effective as of December 23, 2024, indicating that the information is for a specific date rather than a range.
  1. Measurement Units:
  • Currency: The financial figures are reported in USD (United States Dollars).
  • Shares: The report mentions shares as a unit of measure, indicating that share performance or transactions could be part of the reporting.
  1. Regulatory References:
  • Schema Reference: The document refers to an XBRL schema (elab-20241223.xsd), which suggests the filing is structured according to the eXtensible Business Reporting Language for better data handling and analysis.

Insights:

  • The filing indicates that PMGC Holdings Inc. is actively reporting significant corporate events or changes.
  • The presence of the ticker symbol ELAB suggests that the company is publicly traded and subject to SEC regulations, highlighting its obligation for transparency.
  • The specific focus on the date (December 23, 2024) may suggest recent developments or impending corporate actions that stakeholders should be aware of.

Conclusion:

This section of the financial report is essential for understanding the current state of PMGC Holdings Inc. and its public trading status, as well as its compliance with SEC reporting requirements. Further details would be necessary to evaluate the financial health and performance of the company.